ArticleBMC genetics2014

Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients.

Shao-ying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.